Stay updated on LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.6%
    Check dated 2024-12-14T22:47:38.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has updated the contact details for the study, now specifying that the information is for individuals who can answer questions about joining the study, along with a reference to the 'Contacts and Locations' section for further details.
    Difference
    4%
    Check dated 2024-12-07T16:24:52.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-11-30T13:51:06.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Several links related to genetics and specific diseases, including multiple myeloma and various types of leukemia, have been removed from the website.
    Difference
    7%
    Check dated 2024-11-23T04:49:15.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-11-15T23:57:23.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding numerous links related to genetics and various types of leukemia, as well as new options for downloading study data in multiple formats.
    Difference
    8%
    Check dated 2024-11-08T18:29:55.000Z thumbnail image

Stay in the know with updates to LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.